LIVER FIBROSIS

This study tested whether a combination of two drugs, dasatinib and quercetin, could reduce liver scarring (fibrosis) in people with fatty liver disease. Thirty adults with confirmed liver scarring participated in this early-stage trial. The goal was to see if clearing certain ag…

This study tested a new, gentle scanning method (called elastometry) to measure liver scarring (fibrosis) in children. The goal was to see if this scan could be as accurate as a standard liver biopsy, which is invasive and painful. If successful, this scan could help doctors moni…

This study tested new, fully automated MRI scans to diagnose and measure liver scarring and inflammation. The goal was to provide a safer, non-invasive alternative to liver biopsies, which are currently the standard but are painful and carry risks. Researchers compared the MRI re…

This study aimed to find better, non-invasive ways to check for liver scarring (fibrosis) in children with beta-thalassemia, a blood disorder that often causes iron overload. Researchers compared simple blood tests and a special scan against each other to see which was most accur…

This study aimed to understand how HIV medications might cause long-term liver damage and scarring. Researchers enrolled 127 HIV-positive adults who had been on stable HIV drug regimens for at least a year and had elevated liver enzymes for six months. They performed detailed tes…